NEW ENGLAND JOURNAL OF MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2019-03-20 大21

已经with editor一个半月了。求中

1797 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2021-08-16 Spider

偏重的研究方向：临床
经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。

1468 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2018-10-21 12429b29m14(暂无昵称)

请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表:
投image，1周被拒。

hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。

2302 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2012-02-24 匿名用户

近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~

1738 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2022-05-30 fwwchina

sumitting letter to editor cant be published due to limited space

402 0

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2020-07-14 永圣

投稿一篇image，快三月了，原地with editor

4 10

展开10条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2022-04-13 IMzhouyu

审稿速度:5.0 | 投稿命中率:25.0
偏重的研究方向：1
经验分享：AAAA

637 0

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2022-03-22 ms3000000219986740

审稿速度:24.0 | 投稿命中率:5.0
经验分享：-

891 0

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2021-09-27 文多多钱多多房多多

审稿速度:1.0 | 投稿命中率:5.0
偏重的研究方向：临床研究
经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。

850 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=568335, encodeId=01a85683351a, content=已经with editor一个半月了。求中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1797, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK4AmMYFOBCm15vMrL1diaXoLFt5TXicEBeIic6TdMRtjf7RbqFnjiaRKlYSbxk6O6bv7AJw4sgw3aibcQ/132, createdBy=0f882059323, createdName=大21, createdTime=Wed Mar 20 00:00:00 CST 2019, time=2019-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1008296, encodeId=b2ac100829655, content=偏重的研究方向：临床 经验分享：评论的letter一般审多久？什么流程？我的已经with editor快2月了。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1468, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/cef939b4dd64cf27ed24e16b17df7cf3.jpg, createdBy=a9282054067, createdName=Spider, createdTime=Mon Aug 16 12:29:43 CST 2021, time=2021-08-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=562217, encodeId=ebad56221ed5, content=请问投image该怎么写letters啊，谢谢hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, beContent=hukuisuda 2015-11-17 17:05:00 发表: 投image，1周被拒。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2302, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ec4d2466094, createdName=12429b29m14(暂无昵称), createdTime=Sun Oct 21 00:00:00 CST 2018, time=2018-10-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=486910, encodeId=6ccc486910a0, content=近来投了IMAGE IN CLINICAL MEDICINE,不知道结果怎么样，等吧~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1738, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=, createdTime=Fri Feb 24 18:02:00 CST 2012, time=2012-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1223413, encodeId=4e721223413b2, content=sumitting letter to editor cant be published due to limited space, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=402, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8e91446686, createdName=fwwchina, createdTime=Mon May 30 18:57:19 CST 2022, time=2022-05-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=802805, encodeId=947980280521, content=投稿一篇image，快三月了，原地with editor, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=10, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e31c1656664, createdName=永圣, createdTime=Tue Jul 14 22:16:09 CST 2020, time=2020-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210793, encodeId=365c1210e935c, content=审稿速度:5.0 | 投稿命中率:25.0 偏重的研究方向：1 经验分享：AAAA, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=637, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210920/77f4a659f54849c48f02117729bb4733/4c088361e7e44f759d91c31bfab9c7c1.jpg, createdBy=b9325611540, createdName=IMzhouyu, createdTime=Wed Apr 13 09:30:37 CST 2022, time=2022-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1205038, encodeId=0e82120503851, content=审稿速度:24.0 | 投稿命中率:5.0 经验分享：-, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=891, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6cdc6566156, createdName=ms3000000219986740, createdTime=Tue Mar 22 21:43:57 CST 2022, time=2022-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055215, encodeId=8c241055215ee, content=审稿速度:1.0 | 投稿命中率:5.0 偏重的研究方向：临床研究 经验分享：临床研究，2021-7-31投稿；8-1 Administrative Screening，期间格式修改一次耽误几天；8-5 searching for review； 8-8 out for review； 8-25 reject with comments 回来两个审稿人的意见，加起来很少，但是非常不友好，乱说一通，致命的是说对照组不是标准治疗，我们对照组用的方案在指南里面。。。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=850, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2018/06/29/c68ffa2138c126af3420089371aaee39.jpg, createdBy=b9481711950, createdName=文多多钱多多房多多, createdTime=Mon Sep 27 03:34:50 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=995896, encodeId=6f7a99589667, content=请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1041, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=e2531707920, createdName=舍贝罗, createdTime=Sat Jul 03 21:18:27 CST 2021, time=2021-07-03, status=1, ipAttribution=)]

2021-07-03 舍贝罗

请问大佬，Images in Clinical Medicine，对图片的 Panel数有没有要求，稿约里面没看到有写，能不能拼成九宫格（九张小图合成一张大图）

1041 1

展开1条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务